Project Grant K01AI180291

Award Date 6/18/24
Completion Date 5/31/28
Dollars Obligated $129K
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Durham, NC 27710, USA
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $702,204 Cooperative Agreement under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the London School of Hygiene and Tropical Medicine (LSHTM) to conduct research on complex malaria in India. The key products and services to be delivered through this 5-year project include: Monitoring the changing epidemiology of malaria in Odisha, India through a 4-year community-based cohort study to...
This federal Project Grant award, funded by the National Institutes of Health (NIH) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to develop a genomic surveillance approach for monitoring the emergence of artemisinin resistance in Plasmodium falciparum malaria parasites in Africa. The total funding award is $1,553,810.00 and the project period runs from December 1, 2024 to November 30, 2029. The key objectives of this research project are to: 1) identify parasite...
This $1,373,790 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to optimize the structural features of the antimalarial compound ELQ-596, with the goal of developing a next generation of ELQ compounds for once-monthly oral prophylaxis against malaria in humans. The research team, led by Oregon Health & Science University, is working to enhance the intrinsic anti-plasmodial...
This Project Grant from the National Science Foundation's Social, Behavioral, and Economic Sciences program ($405,515) supports research from March 2021 to February 2024 titled "NEW SPATIALLY EXPLICIT APPROACHES FOR ESTIMATING MALARIA PARASITE MIGRATION." The University of Maryland, College Park is developing new spatial modeling techniques to estimate the migration of malaria parasites. A subaward to the University of Maryland, Baltimore expands the research to surface spatially...
This federal Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports a longitudinal cohort study to examine the impact of early childhood malaria prevention interventions on malaria risk in school-age children in Ghana. The study, titled "IMPACT OF EARLY CHILDHOOD MALARIA PREVENTION ON MALARIA RISK AT SCHOOL ENTRY (ERASE)", will evaluate the epidemiological and...
The federal Project Grant award of $459,131, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research (CFDA 93.855) program, supports research to identify essential functions of the mitochondrion in malaria parasites. The goal is to uncover novel drug targets within the parasite mitochondrion that could lead to the development of new antimalarial treatments effective against both symptomatic and transmission stages of malaria...
The National Institute of Allergy and Infectious Diseases (NIAID), through the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $587,318 Project Grant to Oregon Health & Science University (OHSU) to optimize the structural features of the anti-malarial compound ELQ-596. The goal is to develop a next-generation ELQ compound for once-monthly oral prophylaxis against malaria in humans. This would simplify the dosing regimen, improve compliance, decrease the dose and...
This Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will provide $606,815.00 to Duquesne University to develop field-ready paratransgenic bacterial strains that can interfere with the ability of mosquitoes to transmit malaria parasites. The project will focus on engineering Asaia bogorensis strains that lack antibiotic resistance genes, are highly resistant to horizontal...
This $800,000 Project Grant, awarded by the National Science Foundation (NSF) Biological Sciences (CFDA 47.074) program, supports research to study the generation, maintenance, and function of extrachromosomal DNA (eDNA) in the malaria parasite Plasmodium. Key objectives include evaluating the connections between chromosomal genes and eDNA, the propensity for eDNA diversity, the cellular pathways and sequences contributing to eDNA generation and stability, and the clustering of eDNA within the...
This $133,664 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to characterize the network of vector-host-virus interactions within the Mar Chiquita Lake and Bañados del Río Dulce wetland in Argentina. The key objectives are to: 1) identify host bloodmeals in wetland mosquitoes to elucidate viral flow between resident and migratory birds, 2) analyze prior exposure of...

EFFECTIVELY LINKING MOLECULAR INFORMATICS AND NETWORK ANALYTICS TO REDUCE MALARIA (ELIMINAR-MALARIA) - UNDERSTANDING HUMAN MOBILITY IS CRITICAL TO ACHIEVING MALARIA ELIMINATION. THIS IS PARTICULARLY IMPORTANT IN REGIONS SUCH AS THE AMAZON, WHICH HAS THE GOAL OF ELIMINATING MALARIA BY 2030, AND WHERE DECLINING INCIDENCE RATES ARE LEADING CASES TO BECOME INCREASINGLY CLUSTERED INTO NETWORKS OF VILLAGES THAT ARE CONNECTED DUE TO HUMAN MOBILITY AND OTHER ENVIRONMENTAL FACTORS. THESE NETWORKS AND VILLAGES ARE THEREFORE AT RISK OF MALARIA IMPORTATION. HOWEVER, EFFORTS TO UNDERSTAND HOW HUMAN MOBILITY CONTRIBUTES TO IMPORTATION AND DIFFUSION ARE EITHER INCOMPLETE OR ILL-SUITED TO THE AMAZON CONTEXT. FOR EXAMPLE, WHILE MOBILE PHONE DATA HAVE BEEN USED TO TRACK MOBILITY IN A NUMBER OF SETTINGS, COVERAGE IS NONEXISTENT IN THE RURAL AMAZON, AND IS OTHERWISE UNABLE TO CAPTURE THE MANY DIFFERENT REASONS PEOPLE TRAVEL. OTHER APPROACHES IN THE REGION HAVE LEVERAGED GPS TRACKING OR INDIVIDUAL-LEVEL, PARTICIPATORY MAPPING APPROACHES, WHICH CANNOT BE EASILY SCALED TO COLLECT DATA ACROSS AN ENTIRE REGION TO IDENTIFY METACOMMUNITIES OR QUANTIFY MOBILITY WITHIN AND BETWEEN THEM. MOREOVER, NONE OF THESE APPROACHES ARE ABLE TO TRACK PARASITE POPULATIONS. HOWEVER, THE MOLECULAR STUDIES THAT DO SO ARE EITHER COST-PROHIBITIVE OR HAVE INSUFFICIENT COVERAGE OF THE MALARIA GENOME TO INFORM ABOUT IMPORTATION IN INCREASINGLY LOW TRANSMISSION SETTINGS. FINALLY, ALL OF THESE STUDIES IGNORE THE CRUCIAL ROLE THAT COMMUNITY NETWORK TIES HAVE ON HUMAN MOBILITY AND, BY EXTENSION, MALARIA PARASITE STRUCTURE AND IMPORTATION. THEREFORE, THE OBJECTIVE OF THIS PROPOSAL IS TO EFFECTIVELY LINK SCALABLE AND ACTIONABLE NETWORK AND MOLECULAR TOOLS TO UNDERSTAND THE WAYS IN WHICH HUMAN MOBILITY CONTRIBUTES TO MALARIA POPULATION STRUCTURE, IMPORTATION, AND DIFFUSION IN THE NORTHERN PERUVIAN AMAZON. AIM 1 OF THIS PROPOSAL FOCUSES ON COLLECTING PRIMARY COMMUNITY NETWORK DATA TO: 1) QUANTIFY HUMAN MOBILITY PATTERNS, INCLUDING DRIVERS OF MOBILITY AND SEASONAL VARIABILITY, 2) IDENTIFY NETWORKS OF VILLAGES BASED ON MOBILITY PATTERNS, AND 3) QUANTIFY THE EFFECTS OF MOBILITY ON MALARIA TRANSMISSION. AIM 2 WILL LINK THESE COMMUNITY NETWORK DATA WITH GENOMIC SURVEILLANCE OF MALARIA PARASITES TO: 1) IDENTIFY HOW NETWORK STRUCTURE CONTRIBUTES TO MALARIA POPULATION STRUCTURE, AND 2) IDENTIFY SOURCE AND SINK COMMUNITIES OF MALARIA TRANSMISSION, AND 3) QUANTIFY THE EFFECT OF DIFFERENT TYPES OF HUMAN MOBILITY ON MALARIA IMPORTATION BOTH BETWEEN VILLAGES AND BETWEEN NETWORKS OF VILLAGES. THE OVERARCHING HYPOTHESIS IS THAT NETWORK STRUCTURE IS A FUNDAMENTAL DRIVER OF MALARIA POPULATION STRUCTURE, WHILE HUMAN MOBILITY WITHIN AND BETWEEN NETWORKS DRIVES IMPORTATION AND DIFFUSION. THIS PROPOSAL WILL MAKE SIGNIFICANT CONTRIBUTIONS TO ONGOING MALARIA SURVEILLANCE AND CONTROL IN THE REGION, AND BE CONDUCTED IN COLLABORATION WITH PERU'S MALARIA ZERO PROGRAM, WHICH HIS TASKED WITH ELIMINATING MALARIA IN THE REGION.

Posted 6/18/24, 12:00 AM